870
Participants
Start Date
August 19, 2013
Primary Completion Date
August 1, 2026
Study Completion Date
August 1, 2026
capecitabine
capecitabine 1250 milligram (mg) / m² po bid (D1-14)
RECRUITING
Asan Medical Center, Seoul
Lead Sponsor
Ulsan University Hospital
OTHER
Seoul National University Bundang Hospital
OTHER
Gangnam Severance Hospital
OTHER
Seoul National University Boramae Hospital
OTHER
Ajou University School of Medicine
OTHER
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
OTHER
Hallym University Medical Center
OTHER
Inje University Haeundae Paik Hospital
OTHER
Kyung Hee University Hospital
OTHER
Gachon University Gil Medical Center
OTHER
Kangbuk Samsung Hospital
OTHER
Kyungpook National University Hospital
OTHER
Asan Medical Center
OTHER